VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $186.53)
- $186.53 P/E (TTM): 20.86X Cap: $368M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $50.96)
- $50.96 Cap: $20.21B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $186.53)
- $186.53 P/E (TTM): 20.86X Cap: $368M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $51.22)
- $51.22 Cap: $4.93B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $186.53)
- $186.53 P/E (TTM): 20.86X Cap: $368M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $748.87)
- $748.87 P/E (TTM): 18.7X Cap: $79.17B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $238.46)
- $238.46 P/E (TTM): 21.88X Cap: $574.35B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $939.47)
- $939.47 P/E (TTM): 41.54X Cap: $887.62B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $121.42)
- $121.42 P/E (TTM): 16.92X Cap: $300.06B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $26.92)
- $26.92 P/E (TTM): 20.2X Cap: $154.83B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $496.11)
- $496.11 P/E (TTM): 28.38X Cap: $185.91B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $37.52)
- $37.52 P/E (TTM): 10.57X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $169.37)
- $169.37 P/E (TTM): 20.63X Cap: $8.17B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $50.96)
- $50.96 Cap: $20.21B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $186.53)
- $186.53 P/E (TTM): 20.86X Cap: $368M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $87.15)
- $87.15 P/E (TTM): 21.49X Cap: $1B
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023